[1] Lancaster E, Dalmau J.Neuronal autoantigens--pathogenesis, associated disorders and antibody testing[J]. Nat Rev Neurol,2012,8(7):380-390.
[2] Dalmau J, Graus F.Antibody-Mediated Encephalitis[J]. N Engl J Med,2018,378(9):840-851.
[3] Dalmau J, Furneaux HM, Rosenblum MK, et al.Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy[J]. Neurology,1991,41(11):1757-1764.
[4] Corriveau RA, Huh GS, Shatz CJ.Regulation of class I MHC gene expression in the developing and mature CNS by neural activity[J]. Neuron,1998,21(3):505-520.
[5] Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges[J]. Lancet Neurol.2011 Aug;10(8):759-772.
[6] Voltz R, Dalmau J, Posner JB, et al.T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis[J]. Neurology,1998,51(4):1146-1150.
[7] Plonquet A, Gherardi RK, Créange A, et al.Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome[J]. J Neuroimmunol,2002,122(1-2):100-105.
[8] Storstein A, Krossnes BK, Vedeler CA.Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies[J]. Acta Neurol Scand,2009,120(1):64-67.
[9] Pellkofer H, Schubart AS, Höftberger R, et al.Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat[J]. Brain,2004,127(Pt 8):1822-1830.
[10] Belforte JE, Zsiros V, Sklar ER, et al.Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes[J]. Nat Neurosci,2010,13(1):76-83.
[11] Zuliani L, Graus F, Giometto B, et al.Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition[J]. J Neurol Neurosurg Psychiatry,2012,83(6):638-645.
[12] Goodfellow JA, Willison HJ.Guillain-Barré syndrome: a century of progress[J]. Nat Rev Neurol,2016,12(12):723-731.
[13] Cayrol R, Saikali P, Vincent T.Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica[J]. Ann N Y Acad Sci,2009,1173:478-486.
[14] Dalmau J, Rosenfeld MR.Paraneoplastic syndromes of the CNS[J]. Lancet Neurol,2008,7(4):327-340.
[15] Elrington GM, Murray NM, Spiro SG, et al.Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients[J]. J Neurol Neurosurg Psychiatry,1991,54(9):764-767.
[16] Graus F, Delattre JY, Antoine JC, et al.Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry,2004,75(8):1135-1140.
[17] Wingerchuk DM, Banwell B, Bennett JL, et al.International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology,2015,85(2):177-189.
[18] Gresa-Arribas N, Titulaer MJ, Torrents A, et al.Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study[J]. Lancet Neurol,2014,13(2):167-177.
[19] Graus F, Titulaer MJ, Balu R, et al.A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol,2016,15(4):391-404.
